Practice Management

Physician House Calls: An Old Model With a Modern-Day Twist

By

Batya Swift Yasgur, MA, LMSW

To shed light on this re-emerging phenomenon of physician house calls, MPR interviewed three experts.

WHO Updates List of Essential Medicines

The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.

Capping Work Hours in Residency Does Not Affect Later Outcomes

Exposure of U.S. physicians to work-hour reforms during residency training is not associated with post-training differences in patient mortality, readmissions, or costs of care.

Rule Requiring Drug Prices in TV Ads Blocked by Judge

A Trump administration rule to force pharmaceutical companies to disclose the list prices of their drugs in television ads was blocked Monday by a federal judge.

Considerable Number of Patients Receive Surprise Hospital Charges

Eighteen percent of all emergency department visits and 16 percent of in-network hospital stays have at least one out-of-network charge.

Is Artificial Intelligence the Answer to Clinician Burnout?

Multiple leading healthcare organizations have declared clinician burnout a public health crisis. Might artificial intelligence offer a solution to the problem?

Americans Generally Concerned About Clinician Burnout

Nearly three-quarters of Americans are concerned about burnout among their clinicians.

Higher Medicare Spending in Elderly Linked to Lack of Adequate Support

Researchers assessed differences in total Medicare spending among older adults with disability who experience negative consequences citing insufficient support with household activities, mobility, or self-care.

ACP Updates Recommendations for Developing Clinical Guidelines

The American College of Physicians presents new clinical guidelines and guidance statements that address prevention, screening, diagnosis, and treatment of various diseases.

Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads

Three large drug makers have launched a legal challenge against the Trump administration’s rule requiring the prices of drugs to be included in television ads.

Costs of Brand-Name Drugs Have Risen Substantially in the United States

The growth of drug spending in the United States associated with government-protected market exclusivity is likely to continue.